OVCH2
gene geneOn this page
Also known as OVTN
Summary
OVCH2 (ovochymase 2, HGNC:29970) is a protein-coding gene on chromosome 11p15.4, encoding Ovochymase-2 (Q7RTZ1). May be required for sperm ADAM3 processing and consequential sperm fertilizing ability.
Enables serine-type endopeptidase activity. Predicted to be involved in fertilization. Predicted to be located in extracellular region.
Source: NCBI Gene 341277 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_198185
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29970 |
| Approved symbol | OVCH2 |
| Name | ovochymase 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OVTN |
| Ensembl gene | ENSG00000183378 |
| Ensembl biotype | protein_coding |
| OMIM | 618962 |
| Entrez | 341277 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000533663, ENST00000534817, ENST00000612000, ENST00000673880
RefSeq mRNA: 1 — MANE Select: NM_198185
NM_198185
CCDS: CCDS73251
Canonical transcript exons
ENST00000533663 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002174880 | 7695058 | 7695188 |
| ENSE00002180957 | 7689924 | 7690013 |
| ENSE00003576412 | 7691902 | 7691995 |
| ENSE00003630032 | 7691269 | 7691400 |
| ENSE00003712755 | 7700296 | 7700485 |
| ENSE00003716115 | 7701324 | 7701475 |
| ENSE00003716621 | 7706307 | 7706477 |
| ENSE00003718218 | 7702157 | 7702329 |
| ENSE00003718514 | 7698750 | 7698773 |
| ENSE00003719826 | 7695570 | 7695710 |
| ENSE00003722933 | 7703698 | 7703789 |
| ENSE00003725140 | 7704565 | 7704674 |
| ENSE00003734344 | 7696709 | 7696799 |
| ENSE00003735269 | 7701716 | 7701811 |
| ENSE00003751750 | 7696465 | 7696589 |
| ENSE00003896831 | 7689437 | 7689602 |
Expression profiles
Bgee: expression breadth ubiquitous, 111 present calls, max score 80.85.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0437 / max 68.4447, expressed in 5 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 118478 | 0.0160 | 1 |
| 118479 | 0.0157 | 3 |
| 118477 | 0.0119 | 1 |
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.85 | gold quality |
| skin of abdomen | UBERON:0001416 | 80.52 | gold quality |
| zone of skin | UBERON:0000014 | 78.79 | gold quality |
| skin of leg | UBERON:0001511 | 77.53 | gold quality |
| right lung | UBERON:0002167 | 74.90 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 70.42 | gold quality |
| prostate gland | UBERON:0002367 | 69.58 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 69.06 | gold quality |
| ascending aorta | UBERON:0001496 | 68.58 | gold quality |
| thoracic aorta | UBERON:0001515 | 68.48 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 68.42 | gold quality |
| lung | UBERON:0002048 | 67.76 | gold quality |
| kidney | UBERON:0002113 | 66.99 | gold quality |
| minor salivary gland | UBERON:0001830 | 65.88 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 65.85 | gold quality |
| placenta | UBERON:0001987 | 65.81 | gold quality |
| metanephros cortex | UBERON:0010533 | 63.65 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 61.45 | gold quality |
| urinary bladder | UBERON:0001255 | 60.04 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 59.28 | gold quality |
| cortex of kidney | UBERON:0001225 | 58.94 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 58.75 | gold quality |
| endocervix | UBERON:0000458 | 58.17 | gold quality |
| gastrocnemius | UBERON:0001388 | 57.58 | gold quality |
| fallopian tube | UBERON:0003889 | 57.21 | gold quality |
| muscle tissue | UBERON:0002385 | 56.84 | gold quality |
| monocyte | CL:0000576 | 56.48 | gold quality |
| muscle of leg | UBERON:0001383 | 56.43 | gold quality |
| right coronary artery | UBERON:0001625 | 55.74 | gold quality |
| vagina | UBERON:0000996 | 55.19 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.54 |
| E-MTAB-6058 | no | 66.68 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ovch2 | ENSDARG00000094793 |
| mus_musculus | Ovch2 | ENSMUSG00000048236 |
| rattus_norvegicus | Ovch2 | ENSRNOG00000019794 |
Paralogs (3): PRRG3 (ENSG00000130032), PRRG1 (ENSG00000130962), PRRG4 (ENSG00000135378)
Protein
Protein identifiers
Ovochymase-2 — Q7RTZ1 (reviewed: Q7RTZ1)
Alternative names: Oviductin
All UniProt accessions (2): A0A087X1V8, A0A669KBI9
UniProt curated annotations — full annotation on UniProt →
Function. May be required for sperm ADAM3 processing and consequential sperm fertilizing ability. In vitro, has an endopeptidase activity.
Subcellular location. Secreted.
Similarity. Belongs to the peptidase S1 family.
RefSeq proteins (1): NP_937828* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000859 | CUB_dom | Domain |
| IPR001254 | Trypsin_dom | Domain |
| IPR001314 | Peptidase_S1A | Family |
| IPR009003 | Peptidase_S1_PA | Homologous_superfamily |
| IPR018114 | TRYPSIN_HIS | Active_site |
| IPR033116 | TRYPSIN_SER | Active_site |
| IPR035914 | Sperma_CUB_dom_sf | Homologous_superfamily |
| IPR043504 |
Pfam: PF00089, PF00431
UniProt features (31 total): sequence variant 9, disulfide bond 8, glycosylation site 4, domain 3, active site 3, signal peptide 1, propeptide 1, chain 1, binding site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7RTZ1-F1 | 80.47 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 92 (charge relay system); 142 (charge relay system); 240 (charge relay system)
Ligand- & substrate-binding residues (1): 119
Disulfide bonds (8): 77–93, 176–246, 207–225, 236–265, 311–341, 365–384, 431–458, 485–506
Glycosylation sites (4): 104, 415, 451, 530
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
HNF1_Q6, GOBP_FERTILIZATION, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, SUPT16H_TARGET_GENES, DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS, DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS, DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS, DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS, BDP1_TARGET_GENES, GOMF_SERINE_HYDROLASE_ACTIVITY, GOBP_SEXUAL_REPRODUCTION, GOBP_REPRODUCTIVE_PROCESS, GOMF_ENDOPEPTIDASE_ACTIVITY, KONDO_PROSTATE_CANCER_WITH_H3K27ME3
GO Biological Process (2): proteolysis (GO:0006508), fertilization (GO:0009566)
GO Molecular Function (5): serine-type endopeptidase activity (GO:0004252), metal ion binding (GO:0046872), peptidase activity (GO:0008233), serine-type peptidase activity (GO:0008236), hydrolase activity (GO:0016787)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| cation binding | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| peptidase activity | 1 |
| serine hydrolase activity | 1 |
| catalytic activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
562 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OVCH2 | OR52N1 | Q8NH53 | 648 |
| OVCH2 | OR52N5 | Q8NH56 | 645 |
| OVCH2 | SLC7A10 | Q9NS82 | 521 |
| OVCH2 | TRIB2 | Q92519 | 464 |
| OVCH2 | CNTN5 | O94779 | 438 |
| OVCH2 | CYB5R2 | Q6BCY4 | 405 |
| OVCH2 | OR2T35 | Q8NGX2 | 397 |
| OVCH2 | CPXM2 | Q8N436 | 374 |
| OVCH2 | SYT6 | Q5T7P8 | 371 |
| OVCH2 | OLFML1 | Q6UWY5 | 370 |
| OVCH2 | NMRAL1 | Q9HBL8 | 357 |
| OVCH2 | WFDC9 | Q8NEX5 | 356 |
| OVCH2 | CTBS | Q01459 | 353 |
| OVCH2 | TRIP11 | Q15643 | 349 |
| OVCH2 | LCE5A | Q5TCM9 | 328 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A182C2Z2, A0A1S4GMJ4, A6MFK8, B5G6G5, O15393, O60235, O70244, O96900, P00750, P05156, P11214, P19637, P25723, P29598, P79953, P81428, P82807, P83370, P86091, P97435, P98072, P98073, P98074, P98119, P98121, Q05589, Q14C59, Q17800, Q20176, Q4QXT9, Q58L93, Q58L94, Q5QSK2, Q5R5A4, Q5R8J0, Q61129, Q66TN7, Q6DIV5, Q6IE14, Q6ZMR5
Diamond homologs: A0A126GUP6, A0A182C2Z2, A0A1S4H5M5, A8JUP7, B5U2W0, B7YZU2, F5HKX0, O15393, O35453, O60235, O60259, O97366, P00774, P03951, P03952, P05049, P05981, P08419, P09871, P10323, P13582, P14272, P21902, P23578, P25155, P26262, P28175, P29293, P31394, P33587, P35035, P35036, P35037, P35039, P35041, P35045, P35046, P35047, P40313, P48038
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2118 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:7691451:CCA:C | acceptor_gain | 1.0000 |
| 11:7691452:C:CT | acceptor_gain | 1.0000 |
| 11:7691452:C:T | acceptor_gain | 1.0000 |
| 11:7691453:A:AC | acceptor_gain | 1.0000 |
| 11:7691453:A:C | acceptor_gain | 1.0000 |
| 11:7691457:C:CT | acceptor_gain | 1.0000 |
| 11:7691458:A:C | acceptor_gain | 1.0000 |
| 11:7691458:A:T | acceptor_gain | 1.0000 |
| 11:7691459:T:C | acceptor_gain | 1.0000 |
| 11:7691459:T:TC | acceptor_gain | 1.0000 |
| 11:7691904:ATTT:A | donor_gain | 1.0000 |
| 11:7691914:T:TA | donor_gain | 1.0000 |
| 11:7696707:A:AC | donor_gain | 1.0000 |
| 11:7696708:C:CC | donor_gain | 1.0000 |
| 11:7691441:C:T | acceptor_gain | 0.9900 |
| 11:7691442:A:T | acceptor_gain | 0.9900 |
| 11:7691444:CAGA:C | acceptor_gain | 0.9900 |
| 11:7691453:A:T | acceptor_gain | 0.9900 |
| 11:7691458:A:AC | acceptor_gain | 0.9900 |
| 11:7691660:T:A | donor_gain | 0.9900 |
| 11:7691994:AG:A | acceptor_gain | 0.9900 |
| 11:7696708:CTG:C | donor_gain | 0.9900 |
| 11:7696795:CCAGG:C | acceptor_gain | 0.9900 |
| 11:7696796:CAGGC:C | acceptor_gain | 0.9900 |
| 11:7702151:GTTTA:G | donor_loss | 0.9900 |
| 11:7702152:TTTA:T | donor_loss | 0.9900 |
| 11:7702153:TTA:T | donor_loss | 0.9900 |
| 11:7702154:TAC:T | donor_loss | 0.9900 |
| 11:7702155:A:C | donor_loss | 0.9900 |
| 11:7702156:C:CG | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000078500 (11:7707281 A>C,G), RS1000230259 (11:7681910 C>T), RS1000455862 (11:7702571 T>C,G), RS1000482087 (11:7678961 A>T), RS1000763760 (11:7704035 C>T), RS1001053811 (11:7687306 G>A), RS1001164234 (11:7693323 A>G), RS1001261401 (11:7693037 A>G), RS1001568578 (11:7696109 G>A), RS1001615462 (11:7684873 C>A,G), RS1001898738 (11:7704369 G>A), RS1002013266 (11:7702041 C>T), RS1002065710 (11:7702374 T>A,C), RS1002169728 (11:7697703 C>T), RS1002218323 (11:7686214 T>C)
Disease associations
OMIM: gene MIM:618962 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000427_2 | Waist circumference | 5.000000e-06 |
| GCST010463_20 | Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism | 5.000000e-06 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.